JCR Pharmaceuticals Co.,Ltd. 4552Short Interest
Estimated short interest in JCR Pharmaceuticals Co.,Ltd. (4552) is 2.39% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Barclays Capital Securities Ltd, GOLDMAN SACHS INTERNATIONAL, Morgan Stanley MUFG Securities Co., Ltd.
Estimated short interest
2.39%
±0.00%
Estimated position (shares)
3,110,068
As of 2026-11-18
Holders (0.5% or more)
3 firms
310 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 6 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2023-07-14 |
|---|---|
| Latest disclosure | 2026-11-13 (Morgan Stanley MUFG Securities Co., Ltd., 0.53%) |
| Reporting institutions | 10 firms (310 reports) |
| Peak estimated short interest | 5.06% (2026-08-17, 5 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Barclays Capital Securities Ltd
- GOLDMAN SACHS INTERNATIONAL
- Morgan Stanley MUFG Securities Co., Ltd.
- Citigroup Global Markets Limited
- Integrated Core Strategies (Asia) Pte. Ltd.
- Others
2.39%
Estimated short interest, 2026-11-18
Morgan Stanley MUFG Securities Co., Ltd.0.53%
GOLDMAN SACHS INTERNATIONAL0.90%
Barclays Capital Securities Ltd0.96%
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-12 | Barclays Capital Securities Ltd | Position 1,246,123 shares | Ratio 0.96% | ▼0.04% | Holding |
| 2026-11-02 | GOLDMAN SACHS INTERNATIONAL | Position 1,169,681 shares | Ratio 0.90% | ▲0.02% | Holding |
| 2026-11-13 | Morgan Stanley MUFG Securities Co., Ltd. | Position 694,264 shares | Ratio 0.53% | ▲0.13% | Holding |
| 2025-09-18 | UBS AG | Position 637,721 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-08-19 | MERRILL LYNCH INTERNATIONAL | Position 589,356 shares | Ratio 0.45% | ▼0.05% | Below 0.5% |
| 2024-09-03 | JPM Securities Japan Co Ltd. | Position 567,829 shares | Ratio 0.43% | ▼0.10% | Below 0.5% |
| 2026-02-05 | Nomura International plc | Position 531,954 shares | Ratio 0.41% | ▼0.13% | Below 0.5% |
| 2026-11-05 | Citigroup Global Markets Limited | Position 524,678 shares | Ratio 0.40% | ▼0.19% | Below 0.5% |
| 2025-10-21 | Qube Research & Technologies Limited | Position 235,600 shares | Ratio 0.18% | ▼0.32% | Below 0.5% |
| 2025-02-28 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 0 shares | Ratio 0.00% | ▼0.60% | Closed |
Disclosure History 310 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-13 | Morgan Stanley MUFG Securities Co., Ltd. | Position 694,264 shares | Ratio 0.53% | ▲0.13% | — |
| 2026-11-12 | Barclays Capital Securities Ltd | Position 1,246,123 shares | Ratio 0.96% | ▼0.04% | — |
| 2026-11-11 | Barclays Capital Securities Ltd | Position 1,303,323 shares | Ratio 1.00% | ▲0.03% | — |
| 2026-11-05 | Citigroup Global Markets Limited | Position 524,678 shares | Ratio 0.40% | ▼0.19% | Below 0.5% |
| 2026-11-04 | Citigroup Global Markets Limited | Position 769,578 shares | Ratio 0.59% | ▼0.11% | — |
| 2026-11-02 | GOLDMAN SACHS INTERNATIONAL | Position 1,169,681 shares | Ratio 0.90% | ▲0.02% | — |
| 2026-11-02 | Barclays Capital Securities Ltd | Position 1,262,523 shares | Ratio 0.97% | ▼0.07% | — |
| 2026-11-02 | Citigroup Global Markets Limited | Position 917,778 shares | Ratio 0.70% | ▼0.20% | — |
| 2026-10-30 | Citigroup Global Markets Limited | Position 1,178,278 shares | Ratio 0.90% | ▼0.16% | — |
| 2026-10-30 | Barclays Capital Securities Ltd | Position 1,358,601 shares | Ratio 1.04% | ▼0.09% | — |
| 2026-10-29 | GOLDMAN SACHS INTERNATIONAL | Position 1,144,781 shares | Ratio 0.88% | ▼0.11% | — |
| 2026-10-29 | Citigroup Global Markets Limited | Position 1,382,978 shares | Ratio 1.06% | ▼0.85% | — |
| 2026-10-29 | Barclays Capital Securities Ltd | Position 1,469,101 shares | Ratio 1.13% | ▼0.17% | — |
| 2026-10-27 | Citigroup Global Markets Limited | Position 2,482,593 shares | Ratio 1.91% | ▲0.07% | — |
| 2026-10-27 | Barclays Capital Securities Ltd | Position 1,686,001 shares | Ratio 1.30% | ▲0.01% | — |
| 2026-10-23 | Citigroup Global Markets Limited | Position 2,387,243 shares | Ratio 1.84% | ▲0.08% | — |
| 2026-10-20 | Barclays Capital Securities Ltd | Position 1,682,901 shares | Ratio 1.29% | ▼0.03% | — |
| 2026-10-19 | GOLDMAN SACHS INTERNATIONAL | Position 1,295,981 shares | Ratio 0.99% | ▼0.08% | — |
| 2026-10-13 | GOLDMAN SACHS INTERNATIONAL | Position 1,392,081 shares | Ratio 1.07% | ▼0.05% | — |
| 2026-10-13 | Citigroup Global Markets Limited | Position 2,282,843 shares | Ratio 1.76% | ▼0.04% | — |
| 2026-10-09 | Barclays Capital Securities Ltd | Position 1,720,701 shares | Ratio 1.32% | ▼0.13% | — |
| 2026-10-09 | Citigroup Global Markets Limited | Position 2,337,643 shares | Ratio 1.80% | ▲0.13% | — |
| 2026-10-07 | Citigroup Global Markets Limited | Position 2,171,243 shares | Ratio 1.67% | ▲0.19% | — |
| 2026-10-07 | Morgan Stanley MUFG Securities Co., Ltd. | Position 617,764 shares | Ratio 0.47% | ▼0.05% | Below 0.5% |
| 2026-10-06 | GOLDMAN SACHS INTERNATIONAL | Position 1,462,081 shares | Ratio 1.12% | ▼0.12% | — |
| 2026-10-06 | Citigroup Global Markets Limited | Position 1,924,343 shares | Ratio 1.48% | ▲0.39% | — |
| 2026-10-06 | Barclays Capital Securities Ltd | Position 1,881,645 shares | Ratio 1.45% | ▼0.13% | — |
| 2026-10-05 | GOLDMAN SACHS INTERNATIONAL | Position 1,614,981 shares | Ratio 1.24% | ▲0.23% | — |
| 2026-10-05 | Barclays Capital Securities Ltd | Position 2,052,945 shares | Ratio 1.58% | ▲0.61% | — |
| 2026-10-05 | Morgan Stanley MUFG Securities Co., Ltd. | Position 679,564 shares | Ratio 0.52% | ▼0.16% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| NIPPON CHEMIPHAR CO.,LTD.4539 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TSUMURA & CO.4540 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| KISSEI PHARMACEUTICAL CO.,LTD.4547 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| SEIKAGAKU CORPORATION4548 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| EIKEN CHEMICAL CO.,LTD.4549 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| TOWA PHARMACEUTICAL CO.,LTD.4553 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| Fuji Pharma Co.,Ltd.4554 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| CHUKYO IYAKUHIN CO.,LTD.4558 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| ZERIA PHARMACEUTICAL CO.,LTD.4559 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| AnGes,Inc.4563 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |